Evidence map›Paper›PMID 23962103›Full record

ArticleAmerican journal of respiratory cell and molecular biology2014

Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.

Jingning Lu, Linda Auduong, Eric S White, Xinping Yue

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2019
    Review
  20. Extracellular matrix in lung development, homeostasis and disease.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jingning Lu1 Department of Physiology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana; and.
Linda Auduong
Eric S White
Xinping Yue
Louisiana State University Health Sciences Center New Orleans · USUniversity of Michigan · US

Funding

VASCULAR SMOOTH MUSCLE PLASTICITY IN NITRIC OXIDEP20RR018766 · NCRR · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2003 to 2011
$18.5M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Matrix and Bioreactors for Human Lung RegenerationU01HL111016 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E, WHITE, ERIC S · 2012 to 2016
$3.2M
MENTORING IN CARDIOVASCULAR BIOLOGYP20GM103514 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2012 to 2012
$2.0M
Role of Heparan Sulfate 6-O-Endosulfatase 1 and 2 in Pulmonary FibrosisR21HL095865 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI YUE, XINPING · 2010 to 2011
$398k
Expression of Heparan Sulfate 6-O-Endosulfatases in Idiopathic Pulmonary FibrosisR03HL096949 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI YUE, XINPING · 2009 to 2010
$149k
NCRR NIH HHS P20 RR018766NHLBI NIH HHS HL095865NHLBI NIH HHS R03 HL096949NHLBI NIH HHS R21 HL095865NHLBI NIH HHS U01 HL111016NIGMS NIH HHS P20 GM103514NIGMS NIH HHS P41 GM103390NIGMS NIH HHS P41GM103390
6 · The paper itself

Abstract

Heparan sulfate proteoglycans (HSPGs) are integral components of the lung. Changes in HSPGs have been documented in idiopathic pulmonary fibrosis (IPF). Many of the biological functions of HSPGs are mediated by heparan sulfate (HS) side chains, and little is understood about these side chains in the pathogenesis of IPF. The aims of this study were to compare HS structure between normal and IPF lungs and to examine how changes in HS regulate the fibrotic process. HS disaccharide analysis revealed that HS 6-O-sulfation was significantly increased in IPF lungs compared with normal lungs, concomitant with overexpression of HS 6-O-sulfotransferases 1 and 2 (HS6ST1/2) mRNA. Immunohistochemistry revealed that HS6ST2 was specifically expressed in bronchial epithelial cells, including those lining the honeycomb cysts in IPF lungs, whereas HS6ST1 had a broad expression pattern. Lung fibroblasts in the fibroblastic foci of IPF lungs expressed HS6ST1, and overexpression of HS6ST1 mRNA was observed in primary lung fibroblasts isolated from IPF lungs compared with those from normal lungs. In vitro, small interference RNA-mediated silencing of HS6ST1 in primary normal lung fibroblasts resulted in reduced Smad2 expression and activation and in reduced expression of collagen I and α-smooth muscle actin after TGF-β1 stimulation. Similar results were obtained in primary IPF lung fibroblasts. Furthermore, silencing of HS6ST1 in normal and IPF lung fibroblasts resulted in significant down-regulation of TβRIII (betaglycan). In summary, HS 6-O-sulfation is up-regulated in IPF with overexpression of HS6ST1 and HS6ST2, and overexpression of HS6ST1 in lung fibroblasts may regulate their fibrotic responses to TGF-β1.

Indexed as

ActinsBronchiCollagen Type IDown-RegulationEpithelial CellsFemaleHeparan SulfateHumansIdiopathic Pulmonary FibrosisLungMaleMiddle AgedProteoglycansReceptors, Transforming Growth Factor betaRNA, MessengerSmad2 ProteinACTA2 protein, humanActinsbetaglycanCollagen Type IHeparan SulfateHS6ST2 protein, humanProteoglycansReceptors, Transforming Growth Factor betaRNA, MessengerSmad2 ProteinSMAD2 protein, humanSulfotransferases

Identifiers

PMID23962103
PMCPMC3930936
OpenAlexW2137970334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.